126 related articles for article (PubMed ID: 10714493)
41. In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems.
Weiss WJ; Mikels SM; Petersen PJ; Jacobus NV; Bitha P; Lin YI; Testa RT
Antimicrob Agents Chemother; 1999 Mar; 43(3):460-4. PubMed ID: 10049251
[TBL] [Abstract][Full Text] [Related]
42. A novel 1beta-methylcarbapenem, J-111,225: effects of the C-3 and C-5 stereochemistry of the pyrrolidinylthio side chain on antibacterial activities.
Imamura H; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Nagano R; Yamada K; Hashizume T; Morishima H
J Antibiot (Tokyo); 2000 Mar; 53(3):314-6. PubMed ID: 10819306
[No Abstract] [Full Text] [Related]
43. Synthesis and biological evaluation of novel 1 beta-methylcarbapenems with isothiazoloethenyl side chains.
Kang YK; Lee KS; Yoo KH; Shin KJ; Kim DC; Lee CS; Kong JY; Kim DJ
Bioorg Med Chem Lett; 2003 Feb; 13(3):463-6. PubMed ID: 12565951
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological properties of substituted 1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acids.
Miyamoto H; Yamashita H; Ueda H; Tamaoka H; Ohmori K; Nakagawa K
Bioorg Med Chem; 1995 Dec; 3(12):1699-706. PubMed ID: 8770395
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(1,2-disubstituted ethyl)pyrrolidin-3-ylthio]carbapenem derivatives.
Ahn SH; Jeon H; Choi JH; Baek D; Seo SH; Cho JH; Oh CH
Arch Pharm (Weinheim); 2006 Feb; 339(2):67-73. PubMed ID: 16429454
[TBL] [Abstract][Full Text] [Related]
46. New penem compounds with 5'-substituted pyrrolidinylthio group as a C-2 side chain; comparison of their biological properties with those of carbapenem compounds.
Sunagawa M; Matsumura H; Inoue T; Fukasawa M
J Antibiot (Tokyo); 1992 Apr; 45(4):500-4. PubMed ID: 1592682
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships for interactions between carbapenems and beta-lactamases.
Sumita Y; Nouda H; Shinagawa H; Yamaga H; Sunagawa M
J Antibiot (Tokyo); 1995 Feb; 48(2):188-90. PubMed ID: 7706134
[No Abstract] [Full Text] [Related]
48. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and antibacterial activities of new 1beta-methylcarbapenems having aminopyrimidinylthioether moiety.
Lee KS; Lim JH; Kang YK; Yoo KH; Kim DC; Shin KJ; Kim DJ
Eur J Med Chem; 2006 Nov; 41(11):1347-51. PubMed ID: 16973246
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems Part IV. 2-Alkyl substituents containing cationic heteroaromatics linked via a C-C bond.
Zam HA; Barrett D; Tanaka A; Sasaki H; Matsuda K; Sakurai M; Terasawa T; Shirai F; Chiba T; Matsumoto Y; Tawara S
Bioorg Med Chem; 2001 Apr; 9(4):961-82. PubMed ID: 11354680
[TBL] [Abstract][Full Text] [Related]
51. In vitro antimicrobial activity and structure-activity relationship of C-2 triazolylthio and pyridinylmethylthio carbapenems.
Fiakpui C; Thomas G; Singh MP; Micetich RG; Singh R
J Antibiot (Tokyo); 1996 Feb; 49(2):212-5. PubMed ID: 8621364
[No Abstract] [Full Text] [Related]
52. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.
Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL
J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386
[TBL] [Abstract][Full Text] [Related]
53. Carbapenems: a potent class of antibiotics.
Nicolau DP
Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives.
Akbas E; Berber I; Sener A; Hasanov B
Farmaco; 2005 Jan; 60(1):23-6. PubMed ID: 15652364
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
[TBL] [Abstract][Full Text] [Related]
56. 8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agents.
Clark RB; He M; Fyfe C; Lofland D; O'Brien WJ; Plamondon L; Sutcliffe JA; Xiao XY
J Med Chem; 2011 Mar; 54(5):1511-28. PubMed ID: 21302930
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological activity of 1beta-methyl-2-[5-(2-N-substituted aminoethylcarbamoyl)pyrrolidin-3-ylthio]carbapenem derivatives.
Oh CH; Lee SC; Cho JH
Eur J Med Chem; 2003 Sep; 38(9):841-50. PubMed ID: 14561483
[TBL] [Abstract][Full Text] [Related]
58. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological activities of an alpha-methyl and a beta-methyl carbapenem and the corresponding unsubstituted compound.
Pfaendler HR; Weishaupt R; Meffert H
Bioorg Med Chem Lett; 2000 Jun; 10(12):1389-91. PubMed ID: 10890171
[TBL] [Abstract][Full Text] [Related]
60. Parenteral carbapenems.
Shah PM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
